Growth Passive

iShares MSCI EAFE Growth ETF

The iShares MSCI EAFE Growth ETF (the “Fund”) seeks to track the investment results of an index composed of developed market equities, excluding the U.S. and Canada, that exhibit growth characteristics.

$121.77

Key Metrics

TER 0.34% per year
Distribution policy Distributing
Fund size USD 15,176 M
Inception date July 31, 2005
Holdings 388
Fund currency USD
Fund domicile US
Provider iShares
For full official fund details, factsheets, and holdings, visit ishares.com (opens in new tab).

Compare similar ETFs

Fund Size
Dividend
Fees
Current
MSCI EAFE Growth ETF EFG
Fund Size
$15.3B
Dividend
2.3%
Fees
0.34%
Morningstar Growth Index Fund VUG
Fund Size
$380B
Dividend
0.4%
Fees
0.03%
Russell 1000 Growth ETF IWF
Fund Size
$130B
Dividend
0.4%
Fees
0.18%
S&P 500 Growth ETF IVW
Fund Size
$75.1B
Dividend
0.4%
Fees
0.18%
Schwab U.S. Large-Cap Growth ETF SCHG
Fund Size
$61.1B
Dividend
0.4%
Fees
0.04%
View 117 similar ETFs →

Historical Return

Last updated: Sep 01, 2026
1 Year +13.4% +2.3% Div
3 Years (avg.) +10.6% +2.3% Div
5 Years (avg.) +2.0% +2.3% Div

Risk & Analysis Metrics

Last updated: Sep 01, 2026

Volatility

17.52% 1 Year
16.72% 3 Years
18.25% 5 Years
17.57% 10 Years

Max Drawdown

-12.81% 1 Year
-17.44% 3 Years
-36.90% 5 Years
-36.90% 10 Years

Sharpe Ratio

0.49 1 Year
0.40 3 Years
-0.04 5 Years
0.18 10 Years

Return Triangle (Heatmap)

Last updated: Sep 01, 2026
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2011 -15.5% -2.8% 3.5% 1.0% 1.2% 0.4% 3.8% 1.3% 3.7% 4.9% 5.2% 2.4% 3.3% 3.2% 4.1%
2012 11.8% 14.5% 7.2% 5.9% 3.9% 7.4% 3.9% 6.4% 7.4% 7.5% 4.2% 5.0% 4.8% 5.6%
2013 17.2% 4.9% 4.0% 2.0% 6.5% 2.6% 5.7% 6.9% 7.1% 3.4% 4.4% 4.2% 5.2%
2014 -6.2% -2.1% -2.6% 4.0% -0.1% 3.9% 5.5% 5.9% 2.0% 3.2% 3.1% 4.2%
2015 2.2% -0.7% 7.6% 1.5% 6.0% 7.6% 7.7% 3.1% 4.3% 4.0% 5.2%
2016 -3.6% 10.5% 1.3% 7.0% 8.7% 8.7% 3.2% 4.6% 4.3% 5.5%
2017 26.6% 3.9% 10.7% 12.0% 11.3% 4.4% 5.8% 5.3% 6.6%
2018 -14.8% 3.6% 7.5% 7.8% 0.4% 2.7% 2.5% 4.4%
2019 25.9% 20.8% 16.5% 4.6% 6.6% 5.8% 7.4%
2020 15.9% 12.1% -1.6% 2.3% 2.1% 4.6%
2021 8.5% -9.3% -1.9% -1.0% 2.5%
2022 -24.2% -6.7% -4.0% 1.1%
2023 14.8% 8.0% 11.2%
2024 1.6% 9.5%
2025 18.0%

Distributions

*by ETF Portfolio Weight Last updated: Sep 01, 2026

Profit Margin Distribution

< 0%
2%
1y 3y N/A N/A
0 - 5%
4%
1y 3y N/A N/A
5 - 10%
23%
1y 3y N/A N/A
10 - 15%
12%
1y 3y N/A N/A
15 - 20%
9%
1y 3y N/A N/A
20 - 30%
38%
1y 3y N/A N/A
30 - 40%
6%
1y 3y N/A N/A
> 40%
5%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
2%
1y 3y N/A N/A
0 - 10
6%
1y 3y N/A N/A
10 - 15
9%
1y 3y N/A N/A
15 - 20
8%
1y 3y N/A N/A
20 - 25
21%
1y 3y N/A N/A
25 - 35
16%
1y 3y N/A N/A
35 - 50
15%
1y 3y N/A N/A
> 50
23%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap
0.0%
1y 3y N/A N/A
Small Cap
0.0%
1y 3y N/A N/A
Mid Cap
0.6%
1y 3y N/A N/A
Large Cap
61.1%
1y 3y N/A N/A
Mega Cap
38.2%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Portfolio Concentration

*by ETF Portfolio Weight Last updated: Sep 01, 2026
38.7% Top 5 Holdings
57.2% Top 10 Holdings
97.8% Top 50 Holdings
100.0% Top 100 Holdings
Top 5 Companies
ASML ASML Holding NV
14.7%
AZN AstraZeneca Plc
7.7%
NVS Novartis AG
7.4%
SAP Sap SE
4.6%
SMEGF Siemens Energy AG
4.3%

Latest News

6 days ago • benzinga.com

Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling

Dyne Therapeutics Inc. (NASDAQ:DYN) stock is trading lower on Tuesday in reaction to Novartis AG's (NYSE:NVS) data from the global Phase 3 HARBOR s...
6 days ago • 247wallst.com

Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%

A failed cholesterol trial from Novartis (NYSE:NVS | NVS Price Prediction) is dragging the Lp(a) drug class lower and hitting Amgen (NASDAQ:AMGN) h...
6 days ago • reuters.com

Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers

Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis' treatment for a muscle-wasting disorder failed in a trial, fueling inves...

Average metrics of all companies in portfolio

Last updated: Sep 13, 2026
Market
Average
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $228B -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.28% 2.01%
Beta Indicates the relationship between the price performance of a share and the market. 0.84 -
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 32.36 22.99
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -106.88 -
Profitable Companies 97% -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 34.87 18.8
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.73 9.13
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 8.63 11.88
Market
Average
Enterprise Value to EBIT Enterprise Value divided by EBIT 24.22 12.43
Enterprise Value to Revenue Enterprise value divided by revenue 6.7 12.4
Total Debt to Enterprise Value Total debt divided by enterprise value 0.26 0.04
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 0.89 0.32
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 18.15% 21.44%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +24.1% +54.3%
Return on Equity Equity divided by market cap. 24.96% 2.03%
Return on Assets Indicates a company's profitability in relation to its total assets. 10.11% 4.04%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 20.33% 3.73%

Sectors

Manufacturing 15.7%
Health Technology 6.1%
Information 4.3%
Finance and Insurance 2.5%
Finance 1.9%
Producer Manufacturing 1.6%
Consumer Non-Durables 0.9%
Professional, Scientific, and Technical Services 0.7%
Retail Trade 0.6%
Industrials 0.5%
Technology 0.4%
Transportation and Warehousing 0.4%
Healthcare 0.3%
Administrative and Support and Waste Management and Remediation Services 0.3%
Electronic Technology 0.1%
Process Industries 0.0%
Other 63.4%

Countries

Japan 23.2%
United Kingdom 11.2%
Switzerland 10.4%
Netherlands 10.3%
Germany 9.2%
France 7.7%
Australia 6.8%
Sweden 5.2%
Denmark 2.7%
Spain 2.3%
Hong Kong 2.0%
Singapore 1.7%
Italy 1.6%
Israel 1.1%
Belgium 1.1%
Finland 0.8%
Ireland 0.6%
Other 0.6%
Norway 0.5%
New Zealand 0.3%
Austria 0.3%
Luxembourg 0.2%
Portugal 0.2%
Mexico 0.1%
China 0.1%
United States 0.1%
Macao 0.0%
Czechia 0.0%
Other 0.0%

Stock Screener

Select filters to narrow down the 64 investments below

64 companies

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
P/E Ratio
Dividends Ratio of dividends in the last 12 months to current share price
Total Investment
Weight

ASML Holding NV - New York Shares

ASML - Manufacturing

ASML Holding NV - New York Shares

ASML - Manufacturing
Market Cap $654.56B
P/E Ratio 53.6
Dividends 0.5%
Total Investment $828.61M
Weight 5.46%

Loading details…

Astrazeneca plc - ADR

AZN - Health Technology

Astrazeneca plc - ADR

AZN - Health Technology
Market Cap $294.4B
P/E Ratio 23.6
Dividends 2.0%
Total Investment $434.54M
Weight 2.86%

Loading details…

Novartis AG - ADR

NVS - Health Technology

Novartis AG - ADR

NVS - Health Technology
Market Cap $261.86B
P/E Ratio 20.8
Dividends 3.3%
Total Investment $414.94M
Weight 2.73%

Loading details…

Sap SE - ADR

SAP - Information

Sap SE - ADR

SAP - Information
Market Cap $240.46B
P/E Ratio 25.9
Dividends 1.4%
Total Investment $257.51M
Weight 1.70%

Loading details…

Siemens Energy AG

SMEGF - Producer Manufacturing

Siemens Energy AG

SMEGF - Producer Manufacturing
Market Cap $141.68B
P/E Ratio 45.8
Dividends 0.5%
Total Investment $242.55M
Weight 1.60%

Loading details…

ABB Ltd. - ADR

ABB - Manufacturing

ABB Ltd. - ADR

ABB - Manufacturing
Market Cap $69.02B
P/E Ratio 34.8
Dividends 1.2%
Total Investment $234.1M
Weight 1.54%

Loading details…

Hitachi Ltd. - ADR

HTHIY - Manufacturing

Hitachi Ltd. - ADR

HTHIY - Manufacturing
Market Cap $153.41B
P/E Ratio 29.4
Dividends 1.0%
Total Investment $214.3M
Weight 1.41%

Loading details…

UBS Group AG - Registered Shares

UBS - Finance

UBS Group AG - Registered Shares

UBS - Finance
Market Cap $178.9B
P/E Ratio 18.3
Dividends 1.9%
Total Investment $207.46M
Weight 1.37%

Loading details…

Novo Nordisk - ADR

NVO - Manufacturing

Novo Nordisk - ADR

NVO - Manufacturing
Market Cap $191.26B
P/E Ratio 10.5
Dividends 4.2%
Total Investment $201.34M
Weight 1.33%

Loading details…

Airbus SE

EADSF - Manufacturing

Airbus SE

EADSF - Manufacturing
Market Cap $181.38B
P/E Ratio 26.5
Dividends 1.6%
Total Investment $180.91M
Weight 1.19%

Loading details…

Infineon Technologies AG - ADR

IFNNY - Manufacturing

Infineon Technologies AG - ADR

IFNNY - Manufacturing
Market Cap $87.99B
P/E Ratio 63.7
Dividends 0.6%
Total Investment $129.37M
Weight 0.85%

Loading details…

SoftBank Group Corp.

SFTBF - Information

SoftBank Group Corp.

SFTBF - Information
Market Cap $246.72B
P/E Ratio 7.6
Dividends 0.2%
Total Investment $121.57M
Weight 0.80%

Loading details…

Sony Group Corporation - ADR

SONY - Finance and Insurance

Sony Group Corporation - ADR

SONY - Finance and Insurance
Market Cap $140.35B
P/E Ratio -98.8
Dividends 0.7%
Total Investment $117.87M
Weight 0.78%

Loading details…

AIA Group Limited - ADR

AAGIY - Finance and Insurance

AIA Group Limited - ADR

AAGIY - Finance and Insurance
Market Cap $98.65B
P/E Ratio 12.6
Dividends 2.6%
Total Investment $114.11M
Weight 0.75%

Loading details…

Mitsubishi Electric Corporation - ADR

MIELY - Manufacturing

Mitsubishi Electric Corporation - ADR

MIELY - Manufacturing
Market Cap $67.8B
P/E Ratio 24.2
Dividends 1.1%
Total Investment $113.49M
Weight 0.75%

Loading details…

Anheuser-Busch InBev SA/NV - ADR

BUD - Manufacturing

Anheuser-Busch InBev SA/NV - ADR

BUD - Manufacturing
Market Cap $154.07B
P/E Ratio 13.1
Dividends 1.7%
Total Investment $112.34M
Weight 0.74%

Loading details…

RELX Plc - ADR

RELX - Information

RELX Plc - ADR

RELX - Information
Market Cap $59.01B
P/E Ratio 19.6
Dividends 2.8%
Total Investment $97.68M
Weight 0.64%

Loading details…

Prosus NV - ADR

PROSY - Retail Trade

Prosus NV - ADR

PROSY - Retail Trade
Market Cap $90.27B
P/E Ratio 7.8
Dividends 0.6%
Total Investment $94.24M
Weight 0.62%

Loading details…

Tokio Marine Holdings Inc - ADR

TKOMY - Finance and Insurance

Tokio Marine Holdings Inc - ADR

TKOMY - Finance and Insurance
Market Cap $99.34B
P/E Ratio 19.5
Dividends 2.7%
Total Investment $80.79M
Weight 0.53%

Loading details…

Nintendo Co., Ltd.

NTDOF - Manufacturing

Nintendo Co., Ltd.

NTDOF - Manufacturing
Market Cap $61.25B
P/E Ratio 19.7
Dividends 2.7%
Total Investment $80.49M
Weight 0.53%

Loading details…